Literature DB >> 27104897

A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.

Pengcheng Han, Jiong Shi.   

Abstract

Amyloid plaques and Tau protein neurofibrillary tangles are considered the two most important pathogenic factors in Alzheimer's disease. The prevailing amyloid cascade hypothesis suggests that amyloid-β (Aβ) elevation induces downstream Tau hyperphosphorylation and aggregation, synaptic dysfunction, and neuronal loss that ultimately results in cognitive impairment. Alternatively, the dual-pathway hypothesis suggests that Aβ and abnormal Tau are two independent factors that exert synergistic effects on synaptic dysfunction and neuronal loss. We hypothesize that the intrinsic interaction of Aβ and Tau would better predict cognitive impairment. Herein, we propose an Aβ-Tau interactive model based on a review of the medical literature, mathematic modeling, and analysis of our clinicopathological data.

Entities:  

Keywords:  Alzheimer’s disease; Tau; amyloid plaque; neurofibrillary tangle

Mesh:

Substances:

Year:  2016        PMID: 27104897     DOI: 10.3233/JAD-151206

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  3 in total

1.  Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.

Authors:  Daniel T Ohm; Angela J Fought; Alfred Rademaker; Garam Kim; Jaiashre Sridhar; Christina Coventry; Tamar Gefen; Sandra Weintraub; Eileen Bigio; Marek Marsel Mesulam; Emily Rogalski; Changiz Geula
Journal:  Brain Pathol       Date:  2019-09-12       Impact factor: 6.508

2.  Bar-coding neurodegeneration: identifying subcellular effects of human neurodegenerative disease proteins using Drosophila leg neurons.

Authors:  Josefin Fernius; Annika Starkenberg; Stefan Thor
Journal:  Dis Model Mech       Date:  2017-06-14       Impact factor: 5.758

3.  Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation.

Authors:  Woo Shik Shin; Jing Di; Qin Cao; Binsen Li; Paul M Seidler; Kevin A Murray; Gal Bitan; Lin Jiang
Journal:  Alzheimers Res Ther       Date:  2019-10-18       Impact factor: 6.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.